2011

1. Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: A phase Ib study

   International Journal of Gynecological Cancer, Vol. 21, Núm. 3, pp. 478-485